Control of plasma cholesterol-lowering action of probucol with various lipid carrier systems

Biological and Pharmaceutical Bulletin

Volumn 21, Issue 5, 1998, Pages 492-497

  Takino, Toichi ^a   Koreeda, Noriko ^a   Nomura, Takehiko ^a   Sakaeda, Toshiyuki ^b   Yamashita, Fumiyoshi ^a   Takakura, Yoshinobu ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Biodistribution control; Cholesterol lowering action; Lipid carrier system; O w emulsion; Polyoxyethylene hydrogenated castor oil (HCO 60) micelle; Probucol

Indexed keywords

CHOLESTEROL ESTER; DRUG CARRIER; INTRALIPID; LIPID EMULSION; PHOSPHATIDYLCHOLINE; PROBUCOL; RICINOMACROGOL; SOYBEAN OIL; SPHINGOMYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG ELIMINATION; DRUG FORMULATION; DRUG MECHANISM; DRUG RETENTION; HYPERCHOLESTEROLEMIA; INTRAVENOUS DRUG ADMINISTRATION; LIPID COMPOSITION; LIPOPHILICITY; LIVER; MALE; MICELLE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTITION COEFFICIENT;

EID: 0031862874     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.21.492     Document Type: Article

References (19)

1. Yamamoto A., Matsuzawa Y., Kishino B., Hayashi R., Hirobe K., Kikkawa T., Atherosclerosis, 48, 157-166 (1983).
2. Collins-Gold L. C., Lyons R. T., Bartholow L. C., Adv. Drug Delivery Rev., 5, 189-208 (1990).
3. Davis S. S., Washington C., West P., Ann. N. Y. Acad. Sci., 507, 75-88 (1987).
4. Juliano R. L., Adv. Drug Delivery Rev., 1, 31-54 (1988).
5. Kakutani T., Nishihara Y., Takahashi K., Hirano K., Proc. Int. Symp. Control. Rel. Bioact. Mater., 18, 359-360 (1991).
6. Mizushima Y., J. Bioact. Compatible Polymers, 3, 148-156 (1988).
7. Scherphof G. L., "Targeted Drug Delivery," ed. by Juliano R. L., Springer-Verlag, Berlin, 1991, pp. 285-327.
8. Singh M., Ravin L. J., J. Pareter. Sci. Technol., 40, 34-41 (1986).
9. Sakaeda (né Kakutani) T., Takahashi K., Nishihara Y., Hirano K., Biol. Pharm. Bull., 17, 1490-1495 (1997).
10. Takino T., Nakajima C., Takakura Y., Sezaki H., Hashida M., J. Drug Targeting, 1, 117-124 (1993).
11. Takino T., Konishi K., Takakura Y., Hashida M., Biol. Pharm. Bull., 17, 121-125 (1994).
12. Takino T., Nagahama E., Sakaeda (né Kakutani) T., Yamashita F., Takakura Y., Hashida M., Int. J. Pharmaceut., 114, 43-54 (1995).
13. Mansch C., Leo A., Unger S. H., Kim K. H., Nikaitani D., Lien E. J., J. Med. Chem., 16, 207-1216 (1973).
14. Leo A., Jow P. Y. C., Hansch C., J. Med. Chem., 18, 865-868 (1975).
15. Tokunaga Y., Iwasa T., Fujisaki J., Sawai S., Kagayama A., Chem. Pharm. Bull., 36, 3557-3564 (1988).
16. Takakura Y., Fujita T., Hashida M., Sezaki H., Pharm. Res., 7, 339-346 (1990).
17. Allain C. C., Poon L. S., Chan C. S. G., Richmond W., Fu P. C., Clin. Chem., 20, 470-475 (1974).
18. Richmond W., Scand. J. Clin. Lab. Invest., 29, 126 (1972).
19. Richmond W., Clin. Chem., 19, 1350-1356 (1973).